Precision medicine in Type 2 Diabetes: Targeting SGLT2-inhibitor Treatment For Kidney Protection | medRxiv

Article usage

Article usage: September 2024 to June 2025

	Abstract	Full	Pdf
Sep 2024	248	37	101
Oct 2024	51	4	26
Nov 2024	40	0	43
Dec 2024	23	2	13
Jan 2025	40	5	12
Feb 2025	104	7	27
Mar 2025	129	51	53
Apr 2025	81	52	50
May 2025	95	95	67
Jun 2025	26	13	5

View the discussion thread.

Posted September 02, 2024.

Supplementary Material

Subject Area

Endocrinology (including Diabetes Mellitus and Metabolic Disease)

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)